deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT00421213

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

Sponsor: Alaunos Therapeutics

Conditions Bone Marrow Neoplasms Hematologic Neoplasms Non-Hodgkin's Lymphoma
Interventions Darinaparsin
Updated 7 times since 2017 Last updated: Jul 18, 2012 Started: Dec 31, 2006 Primary completion: Apr 30, 2012 Completion: Apr 30, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Bone Marrow Neoplasms and Hematologic Neoplasms, this trial is completed. The trial is conducted by Alaunos Therapeutics and has accumulated 7 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotCompleted~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Mar 2022 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Mar 2022 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 2 earlier versions

  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alaunos Therapeutics
Data source: Alaunos Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations